The Cancer Letter

Inside information on cancer research and drug development

BACK TO CONTRIBUTORS
Danielle N. Krol

Danielle N. Krol

Medical officer, breast oncology, Center of Drug Evaluation and Research, Office of Oncologic Diseases, Division of Oncology 1, FDA

Can you spare 10 minutes to complete a survey?

Your feedback is really important—you're helping us shape our coverage priorities and services to better serve you, our readers.
COMPLETE OUR SURVEY

Login

Site license subscribers:
Log in with your IP | Register a sponsored account